This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.
The 5-minute video shares one man's story with multidrug-resistant TB (MDR TB) and emphasizes the importance of TB treatment. The video includes details about the man's experience with TB symptoms and treatment. The video is in Hmong with English subtitles.
The infographic provides information on the importance of CDC's Molecular Detection of Drug Resistance (MDDR) service, how drug resistance develops, and how CDC assists TB programs. The infographic also includes a case study.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated...
This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.
This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released...
